An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa.
Partson TinarwoTemesgen ZewotirNonhlanhla Yende-ZumaNigel J GarrettDelia NorthPublished in: Infectious diseases and therapy (2019)
Only a few of the many previously suggested continuous CD4+ count clinical covariates showed the potential to become an important integral part of the treatment process. Prolonging the pre-treatment period of the HIV disease progression by effectively incorporating and managing the covariates for long-term influence on the CD4+ cell response has the potential to delay challenges associated with ART side effects.
Keyphrases
- hiv positive
- antiretroviral therapy
- hiv infected
- south africa
- human immunodeficiency virus
- hepatitis c virus
- hiv testing
- men who have sex with men
- hiv aids
- nk cells
- adipose tissue
- single cell
- human health
- peripheral blood
- combination therapy
- polycystic ovary syndrome
- cell therapy
- skeletal muscle
- mesenchymal stem cells
- replacement therapy
- bone marrow